Excitotoxins and the NMDA-receptor exciting times for neuroscience research
Tacke, U.; Ebert, M.H.
Nordisk Medicin 103(6-7): 192-193; 197
1988
ISSN/ISBN: 0029-1420 PMID: 2837725 Document Number: 324285
Document emailed within 1 workday
Related Documents
Barry, S.R. 1991: Clinical implications of basic neuroscience research. II: NMDA receptors and neurotrophic factors Archives of Physical Medicine and Rehabilitation 72(13): 1095-1101Ashcroft, F.M. 1998: Exciting times for PIP2 Science 282(5391): 1059-1060
Bonar, S. 2010: Exciting political times ahead Midwives 2010: 25
Martín-Araguz, A.; Mikola, Y.; Almendral-Doncel, R.; Campos-Bueno, J.; de Cervantes Saavedra, M.; Pereira, G.óm.; Sabuco Alvarez, M.; Huarte de San Juan, J. 2016: Spanish neuroscience in times of Don Quixote Revista de Neurologia 62(4): 179-188
Reimers, D. 1985: Active tuberculosis treatment in former times--nostalgic reminiscences of an exciting therapy era Praxis und Klinik der Pneumologie 39(11): 447-456
Langhoff-Roos, J. 2016: Obstetrical research is exciting Ugeskrift for Laeger 178(30)
Pellicciari, R.; Natalini, B.; Costantino, G.; Garzon, A.; Luneia, R.; Mahmoud, M.R.; Marinozzi, M.; Roberti, M.; Rosato, G.C.; Shiba, S.A. 1993: Heterocyclic modulators of the NMDA receptor Farmaco 48(2): 151-157
Shahand, S.; Caan, M.W.A.; van Kampen, A.H.C.; Olabarriaga, Sílvia.D. 2012: Integrated support for neuroscience research: from study design to publication Studies in Health Technology and Informatics 175: 195-204
Bian, S.-Z.; Zhang, J.; Liu, W.-L.; Sun, Z.-H.; Gu, Z.-L.; Jiang, X.-G. 2009: Receptor antagonist of NMDA and animal models of schizophrenia Fa Yi Xue Za Zhi 25(6): 443-446
Ebert, B.; Madsen, U.; Johansen, T.N.; Krogsgaard-Larsen, P. 1991: NMDA receptor agonists: relationships between structure and biological activity Advances in Experimental Medicine and Biology 287: 483-487
Jahr, C.E. 1992: High probability opening of NMDA receptor channels by L-glutamate Science 255(5043): 470-472
Nagy, J. 2004: Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism? Idrugs: the Investigational Drugs Journal 7(4): 339-350
Kornhuber, J.; Weller, M.; Schoppmeyer, K.; Riederer, P. 1994: Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties Journal of Neural Transmission. Supplementum 43: 91-104
Froeba, G.; Adolph, O. 2012: No need for NMDA-receptor antagonists in women undergoing caesarean section? Minerva Anestesiologica 78(4): 402-403
Wachs, T.D.; Georgieff, M.; Cusick, S.; McEwen, B.S. 2014: Issues in the timing of integrated early interventions: contributions from nutrition, neuroscience, and psychological research Annals of the new York Academy of Sciences 1308: 89-106
Heresco-Levy, U.; Silipo, G.; Javitt, D.C. 1996: Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia Psychopharmacology Bulletin 32(4): 731-740
Mitani, T.; Ohtsuka, Y.; Yamamoto, K.; Watanabe, Y.; Tsuji, M.; Samejima, K.; Aida, N.; Sato, T.; Wada, T.; Osaka, H. 2013: An 8-year-old boy with anti-NMDA receptor encephalitis, successfully treated with cyclophosphamide No to Hattatsu 45(1): 53-57
Kato, T. 2004: Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine Clinical Calcium 14(8): 76-80
Nelson, M.A.; Lochhead, J.D.; Maguire, G.A. 2017: Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 29(3): 205-206
Nayyar, T.; Wu, J.; Hood, D.B. 2003: Downregulation of hippocampal NMDA receptor expression by prenatal exposure to dioxin Cellular and Molecular Biology 49(8): 1357-1362